{"SPADE_N_07184": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07184", "Peptide Name": "Endostatin peptide fragment I (180â€“199)", "Source": "Collagen XVIII", "Family": "", "Gene": "Not found", "Sequence": "FLSSRLQDLYSIVRRADRAA", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C102H169N33O30", "Mass": 2337.64, "PI": 10.67, "Net Charge": 2, "Hydrophobicity": -0.2, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-25.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "RAL", "Absent Amino Acids": "CEGHKMNOPTUW", "Basic Residues": 4, "Acidic Residues": 2, "Hydrophobic Residues": 10, "Polar Residues": 13, "Positive Residues": 4, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06269", "Similarity": 1.0, "Sequence": "TFRAFLSSRLQDLYSIVRRADRAAV"}, {"SPADE_ID": "SPADE_UN_15326", "Similarity": 1.0, "Sequence": "IVRRADRAAVPGGGGACDCRGDCFC"}, {"SPADE_ID": "SPADE_UN_17069", "Similarity": 1.0, "Sequence": "IVRRADRAAVP"}]}}}